Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Long-term Effects of Antihypertensive Drug Use and New-onset Osteoporotic Fracture in Elderly Patients: A Population-based Longitudinal Cohort Study.

Chen HY, Ma KY, Hsieh PL, Liou YS, Jong GP.

Chin Med J (Engl). 2016 20th Dec;129(24):2907-2912. doi: 10.4103/0366-6999.195472.

2.

Diuretic Use and Risk of Vertebral Fracture in Women.

Paik JM, Rosen HN, Gordon CM, Curhan GC.

Am J Med. 2016 Dec;129(12):1299-1306. doi: 10.1016/j.amjmed.2016.07.013.

PMID:
27542612
3.

Risk of hip fracture among older people using antihypertensive drugs: a nationwide cohort study.

Ruths S, Bakken MS, Ranhoff AH, Hunskaar S, Engesæter LB, Engeland A.

BMC Geriatr. 2015 Dec 1;15:153. doi: 10.1186/s12877-015-0154-5.

4.

Bone mineral density changes among women initiating blood pressure lowering drugs: a SWAN cohort study.

Solomon DH, Ruppert K, Zhao Z, Lian YJ, Kuo IH, Greendale GA, Finkelstein JS.

Osteoporos Int. 2016 Mar;27(3):1181-9. doi: 10.1007/s00198-015-3332-6.

5.

Pediatric primary urolithiasis: Symptoms, medical management and prevention strategies.

Penido MG, Tavares Mde S.

World J Nephrol. 2015 Sep 6;4(4):444-54. doi: 10.5527/wjn.v4.i4.444.

6.

Hypertension, Antihypertensive Medications, and Risk of Incident Primary Hyperparathyroidism.

Vaidya A, Curhan GC, Paik JM, Kronenberg H, Taylor EN.

J Clin Endocrinol Metab. 2015 Jun;100(6):2396-404. doi: 10.1210/jc.2015-1619.

7.

Risk of fracture in urolithiasis: a population-based cohort study using the health improvement network.

Denburg MR, Leonard MB, Haynes K, Tuchman S, Tasian G, Shults J, Copelovitch L.

Clin J Am Soc Nephrol. 2014 Dec 5;9(12):2133-40. doi: 10.2215/CJN.04340514.

8.

Comparison of olmesartan combined with a calcium channel blocker or a diuretic in elderly hypertensive patients (COLM Study): safety and tolerability.

Saruta T, Ogihara T, Saito I, Rakugi H, Shimamoto K, Matsuoka H, Teramukai S, Higaki J, Ito S, Shimada K.

Hypertens Res. 2015 Feb;38(2):132-6. doi: 10.1038/hr.2014.141.

9.

Intensive blood pressure control, falls, and fractures in patients with type 2 diabetes: the ACCORD trial.

Margolis KL, Palermo L, Vittinghoff E, Evans GW, Atkinson HH, Hamilton BP, Josse RG, O'Connor PJ, Simmons DL, Tiktin M, Schwartz AV.

J Gen Intern Med. 2014 Dec;29(12):1599-606. doi: 10.1007/s11606-014-2961-3.

10.

The effects of antihypertensive drugs on bone mineral density in ovariectomized mice.

Kang KY, Kang Y, Kim M, Kim Y, Yi H, Kim J, Jung HR, Park SH, Kim HY, Ju JH, Hong YS.

J Korean Med Sci. 2013 Aug;28(8):1139-44. doi: 10.3346/jkms.2013.28.8.1139.

11.

Diuretic initiation and the acute risk of hip fracture.

Berry SD, Zhu Y, Choi H, Kiel DP, Zhang Y.

Osteoporos Int. 2013 Feb;24(2):689-95. doi: 10.1007/s00198-012-2053-3.

12.

Bone disease in primary hypercalciuria.

Sella S, Cattelan C, Realdi G, Giannini S.

Clin Cases Miner Bone Metab. 2008 May;5(2):118-26.

13.

Chlorthalidone improves vertebral bone quality in genetic hypercalciuric stone-forming rats.

Bushinsky DA, Willett T, Asplin JR, Culbertson C, Che SP, Grynpas M.

J Bone Miner Res. 2011 Aug;26(8):1904-12. doi: 10.1002/jbmr.374.

14.

CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

Moher D, Hopewell S, Schulz KF, Montori V, G√łtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG.

BMJ. 2010 Mar 23;340:c869. doi: 10.1136/bmj.c869. No abstract available.

15.

Hyponatremia independent of osteoporosis is associated with fracture occurrence.

Kinsella S, Moran S, Sullivan MO, Molloy MG, Eustace JA.

Clin J Am Soc Nephrol. 2010 Feb;5(2):275-80. doi: 10.2215/CJN.06120809.

17.

Fracture risk and the use of a diuretic (indapamide SR) +/- perindopril: a substudy of the Hypertension in the Very Elderly Trial (HYVET).

Bulpitt CJ, Peters R, Staessen JA, Thijs L, De Vernejoul MC, Fletcher AE, Beckett NS.

Trials. 2006 Dec 19;7:33.

18.

Diuretic use and bone mineral density in older USA men: the osteoporotic fractures in men (MrOS) study.

Lim LS, Fink HA, Kuskowski MA, Cauley JA, Ensrud KE.

Age Ageing. 2005 Sep;34(5):504-7. No abstract available.

19.

Do beta-blockers and thiazides reduce fracture risk?

Bhandari M, Devereaux PJ.

CMAJ. 2005 Jan 4;172(1):37. No abstract available.

Items per page

Supplemental Content

Support Center